Ordering
Available Variants10 mg
CHA.45777-10mg
Price
€100.80
Available – Dispatch in 14 days
50 mg
CHA.45777-50mg
Price
€408.00
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
10 mg | CHA.45777-10mg | €100.80 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
50 mg | CHA.45777-50mg | €408.00 |
≥98% (HPLC)
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C20H19N5O6 · 2Na · 7H2O |
|---|---|
| CAS Number | 357166-29-1 |
| Molecular Weight | 597.48 |
| UNSPSC Code | 12352200 |
| NACRES | NA.77 |
| Assay | ≥98% (HPLC) |
| Form | powder |
| Quality level | 100 |
Safety Information Handling visibility
| pictograms |
GHS08
GHS07
  GHS08,GHS07
|
|---|---|
| signalword | Danger |
| hcodes | H315,H341,H360FD,H372 |
| pcodes | P202 - P260 - P264 - P280 - P302 + P352 - P308 + P313 |
| Hazard Classifications | Muta. 2 - Repr. 1A - Skin Irrit. 2 - STOT RE 1 |
| target_organs | Blood,Immune system,Testes |
| Storage Class | 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects |
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
Pemetrexed disodium heptahydrate, with a CAS number of 150399-23-8, is a chemotherapeutic agent used in the treatment of various cancers, including pleural mesothelioma and non-small cell lung cancer. It functions as an antifolate, inhibiting the enzymes thymidylate synthase, dihydrofolate reductase, and glycinamide ribonucleotide formyltransferase, which are essential for DNA synthesis and cell division. The heptahydrate form of pemetrexed disodium is a white to almost white crystalline powder that is highly soluble in water. Administration of pemetrexed disodium heptahydrate is typically via intravenous infusion, and its efficacy has been demonstrated in clinical trials, both as a single agent and in combination with other chemotherapeutic agents. The drugs mechanism of action and pharmacokinetic properties make it a valuable component of cancer treatment regimens, offering a therapeutic option for patients with specific types of cancer.
